Aarti Drugs Launches 'Saksham Niveshak' Campaign for Unclaimed Dividends
Aarti Drugs relaunches the 'Saksham Niveshak' campaign from April 1 to July 9, 2026. This initiative encourages shareholders to update KYC details and claim unpaid/unclaimed dividends before they are transferred to the IEPF. Shareholders can submit required documents via post, email, or online.
This is an awareness campaign initiated by a regulatory body to help shareholders claim unclaimed dividends. It does not involve new business, financial results, or corporate actions that would significantly affect the company's operations or valuation.
The announcement is a procedural update regarding an investor awareness campaign and does not contain any financial performance data or significant business developments that would directly impact the company's stock price.
Aarti Drugs Limited has announced the relaunch of the Second 100 Days Campaign, named “Saksham Niveshak,” as requested by the Investor Education and Protection Fund Authority (IEPFA) under the Ministry of Corporate Affairs (MCA).
This campaign, running from April 1, 2026, to July 9, 2026, aims to create awareness among shareholders to update their Know Your Customer (KYC) details and claim any unpaid or unclaimed dividends before they are transferred to the IEPF.
Shareholders are advised to update their PAN, Nomination details, contact information, bank account details, and specimen signature with the Registrar & Share Transfer Agent, MUFG Intime India Private Limited, or their Depository Participant. Dividends are payable only through electronic mode, requiring updated information for credit. Shareholders can submit required forms like ISR-1, ISR-2, SH-13, and ISR-3 via post, email, or online through MUFG's portal. Shareholders holding shares in electronic form and yet to claim dividends should update their details with their respective Depository Participants. The company will also send letters/emails detailing unpaid dividends and the claiming process. Shareholders are urged to claim their dividends to avoid transfer to the IEPF. Details of unclaimed/unpaid dividends for the past seven years are available on the company's website. Equity shares with unclaimed dividends for seven consecutive years will be transferred to the IEPF Authority. For assistance, shareholders can contact Aarti Drugs Limited or MUFG Intime India Private Limited.
What to do with a filing like this
Aarti Drugs Limited filed this with the NSE as a statutory disclosure, categorised under general announcements. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aarti Drugs Limited. Read the original for the full detail.